Key result
ABCA1 deficiency increases diet-induced aortic atherosclerotic lesion area up to ~3.3-fold in hamsters.
Why the study?
ABCA1 deficiency in humans is closely linked to atherosclerotic disease, but existing ABCA1 deficient mouse models do not faithfully recapitulate the dyslipidemia and atherosclerotic pathology seen in patients.
Does CRISPR/Cas9-mediated ABCA1 deficiency exacerbate dyslipidemia, diet-induced aortic atherosclerosis, and hepatic xanthomatosis in golden Syrian hamsters?
Does CRISPR/Cas9-mediated ABCA1 deficiency exacerbate dyslipidemia, diet-induced aortic atherosclerosis, and hepatic xanthomatosis in golden Syrian hamsters?
Unlike mouse models, ABCA1 knockout golden Syrian hamsters closely recapitulate human Tangier disease features—including severe HDL deficiency, hypertriglyceridemia, accelerated aortic atherosclerosis with valve calcification, and hepatic xanthomatosis—providing a superior preclinical model for human dyslipidemia and ASCVD.
Answers are grounded in this paper and cite their sources.
ABCA1 KO hamsters exhibit worsened diet-induced aortic lesions; leaves open translation to human ABCA1 deficiency therapies pending further validation.
ATP-binding cassette transporter A1 (ABCA1) is a critical transmembrane protein that mediates the cellular efflux of cholesterol and phospholipids to extracellular acceptors. Lipid metabolism dysfunctions caused by ABCA1 deficiency in humans have been closely linked to atherosclerotic disease. However, ABCA1 deficient mouse models reported so far are inadequate for faithfully recapitulating the characteristics of dyslipidemia and atherosclerotic pathology seen in ABCA1 deficient patients. To overcome this problem, we attempted to use a golden Syrian hamster model because of its lipid metabolism similarities to humans, and generated ABCA1 knockout (KO) hamsters using the CRISPR/Cas9 technique and examined the pathophysiological consequences of ABCA1 deficiency. On a normal chow diet, ABCA1 KO hamsters exhibited significantly lower levels of plasma total cholesterol (TC) but higher levels of plasma triglycerides (TG) compared with the wild-type (WT) controls. Nevertheless, plasma HDLs were nearly undetectable in KO hamsters. On a high-cholesterol high-fat diet, male KO hamsters displayed more pronounced hyperlipidemia with increased levels of plasma TC and TG compared with those in WT controls, a change attributable to a remarkable increase in TC contents in VLDLs and in TG contents in all apoB-containing lipoproteins, whereas cholesterol in IDLs and large LDLs was reduced. Female KO hamsters, in contrast, showed consistently lower plasma TC levels than WT controls. Pathological analysis showed that ABCA1 deficiency not only promoted aortic atherosclerosis but also caused massive hepatic xanthomatosis in KO hamsters. These results indicate that ABCA1 KO hamsters may become a useful model for the study of human dyslipidemia and atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied Atherosclerosis, dyslipidemia, and hepatic xanthomatosis. CRISPR/Cas9-mediated ABCA1 gene knockout with high-cholesterol high-fat diet vs. Wild-type littermates (ABCA1+/+) on the same diet was evaluated on Gross aortic atherosclerotic lesion area (3.3-fold increase in males; 2.2-fold increase in females, p=<0.05). ABCA1 deficiency in golden Syrian hamsters increased high-cholesterol high-fat diet-induced gross aortic atherosclerotic lesion area by 3.3-fold in males and 2.2-fold in females vs wild-type controls.
Synapse has enriched 10 related papers. Consider them for comparative context: